Daily non-political popular news in brief.
Commonly used drug offers promise for premature babies
05-17-2007 · EurekAlert!Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
Read more »
Keywords: commonly, used, drug, offers, promise, premature, babies, offer, baby
« Previous | Next »
Similar news on "Commonly used drug offers promise for premature babies":
- Common drug for stopping preterm labor may be harmful for babies
11-01-2007 · EurekAlert!
A drug commonly used to halt premature labor may be associated with brain damage and intestinal issues in premature babies, according to a new analysis of studies on the issue published today in American Journal of Obstetrics and Gynecology.
Similar news · Read more »
- Drug treatment slows macular vision loss in diabetics
12-15-2006 · EurekAlert!
A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, Johns Hopkins Wilmer Eye Institute scientists report.
Similar news · Read more »
- Experimental MS drug shows promise, offers new window on disease
02-13-2008 · EurekAlert!
A drug therapy currently used to treat non-Hodgkin's lymphoma and rheumatoid arthritis had a significant effect in treating the most common form of multiple sclerosis in a small, short-term clinical trial led by scientists at University of California-San Francisco.
Similar news · Read more »
- Repeat steroids to premature infants linked to cerebral palsy
09-19-2007 · EurekAlert!
Repeated courses of a drug that is used to improve the survival of unborn premature babies also may increase the risk of cerebral palsy in those children, according to results from a multi-center study, funded by the National Institutes of Health and led by Ronald Wapner, M.D., professor of obstetrics and gynecology, Columbia University Medical Center and attending obstetrician and gynecologist at NewYork-Presbyterian Hospital/Columbia.
Similar news · Read more »
- Lead-'scrubbing' drug may also improve muscle function in lead-exposed children
04-24-2007 · EurekAlert!
UC environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.
Similar news · Read more »
- Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
10-30-2007 · EurekAlert!
Nematode worms treated with lithium show a 46 percent increase in lifespan.
Similar news · Read more »
- Intensive care quality of sleep improved by new drug, reports study
12-12-2007 · EurekAlert!
A new sedative drug has been shown to improve the sleep quality and comfort levels of intensive care patients, compared to the most commonly-used medication, according to research published today in the journal JAMA.
Similar news · Read more »
- Targeted nanoparticles incorporating siRNA offer promise for cancer treatment
05-20-2007 · EurekAlert!
The use of targeted nanoparticles offers promising techniques for cancer treatment. Researchers in the laboratory of Mark E. Davis at the California Institute of Technology have been using small interfering RNA (siRNA), sometimes known as silencing RNA, to "silence" specific genes that are implicated in certain malignancies. The results of this research are being presented this week at the NSTI Nanotech 2007 Conference in Santa Clara, Calif.
Similar news · Read more »
- Tequila raw ingredient being developed into drug-carrier that targets colon diseases
03-27-2007 · EurekAlert!
Compounds derived from the blue agave, a fruit used to make tequila, show promise as a natural, more effective way to deliver drugs to the colon than conventional drug-carriers, according to chemists at the University of Guadalajara in Mexico. The discovery could lead to improved treatments for a variety of colon diseases, including ulcerative colitis, irritable bowel and cancer, they say. The research will be presented in March at the American Chemical Society national meeting.
Similar news · Read more »
- Common blood pressure drug treats muscular dystrophy in mice
01-21-2007 · EurekAlert!
Researchers at Johns Hopkins have shown that a drug commonly used to lower blood pressure reverses muscle wasting in genetically engineered mice with Marfan syndrome and also prevents muscle degeneration in mice with Duchenne muscular dystrophy. The results are reported online this week at Nature Medicine.
Similar news · Read more »